CardioSentials® proven effective in clinical trial to lower risk factors for cardiovascular disease

Joe Vinson, Ph.D. and Professor of Chemistry at the University of Scranton, conducted a clinical study to determine the effectiveness of CardioSentials in reducing key risk factors for cardiovascular disease.

The facts:
– Heart disease is the number one cause of death in the U.S.
– Lipid abnormalities like high cholesterol, triglycerides, LDL (“bad cholesterol”) and HDL (“good cholesterol”) are major risk factors for cardiovascular disease.
– Phytosterols have been shown to block the absorption of cholesterol thus benefitting health.

The results:
CardioSentials…
– Reduced average cholesterol by 7%
– Reduced average LDL by 9%
– Increased average HDL by 4%
– Reduced average triglycerides by 13%
– Reduced average fasting glucose by 6%

Full study (PDF)

These statements have not been evaluated by the Food and Drug Administration. Reliv products are not intended to diagnose, treat, cure or prevent any disease.